Elaine R. Mardis - 05 Jan 2022 Form 4 Insider Report for Singular Genomics Systems, Inc.

Role
Director
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
05 Jan 2022
Net transactions value
$0
Form type
4
Filing time
06 Jan 2022, 19:22:50 UTC
Next filing
31 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 05 Jan 2022 Common Stock 40,000 $9.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3rd of the option shares vest and become exercisable on January 5, 2023 with the remaining option shares vesting in 24 equal monthly installments thereafter.